MKI67 and cancer: We speculate that the anti-tumor immune microenvironment shown as higher cytolytic activity associated with “M1” high tumor is offset by its association with highly proliferative cancer shown as enrichment of cell proliferation-related gene sets and high MKI67, which result in insignificant survival difference by “M1” macrophage levels.